JPS5612311A - Carcinostatic agent - Google Patents

Carcinostatic agent

Info

Publication number
JPS5612311A
JPS5612311A JP8724379A JP8724379A JPS5612311A JP S5612311 A JPS5612311 A JP S5612311A JP 8724379 A JP8724379 A JP 8724379A JP 8724379 A JP8724379 A JP 8724379A JP S5612311 A JPS5612311 A JP S5612311A
Authority
JP
Japan
Prior art keywords
agent
administration
compound
oral
effective component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8724379A
Other languages
Japanese (ja)
Other versions
JPS638924B2 (en
Inventor
Setsuo Takeuchi
Mutsuyuki Kochi
Akira Kawarada
Shinichiro Esumi
Kazuya Sasaki
Shozo Kawabata
Tsuneo Saida
Yukio Inoue
Tadasu Yamamoto
Takaharu Sekine
Koji Amamiya
Katsumasa Saga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
RIKEN Institute of Physical and Chemical Research
Original Assignee
Kaken Pharmaceutical Co Ltd
Kaken Chemical Co Ltd
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Kaken Chemical Co Ltd, RIKEN Institute of Physical and Chemical Research filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP8724379A priority Critical patent/JPS5612311A/en
Publication of JPS5612311A publication Critical patent/JPS5612311A/en
Publication of JPS638924B2 publication Critical patent/JPS638924B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To prepare a carcinostatic agent having high sensitivity to the cells cancerized with SV40 carcinogenic virus, and effective to the warm-blooded animal such as man, cattle, dog, cat, etc., by using a specific aromatic aldehyde as an effective component.
CONSTITUTION: An agent containing a compound of formula (n is 1W10). The amount of the effective component is 0.3W15.0wt% for oral or transmucous administration, and 0.01W10wt% for parenteral administration. An aqueous suspension or an oil solution of the compound can be used as a carcinostatic agent for subcutaneous or intravenous injection. It can be formed to capsules or tablets for oral administration. An adjuvant such as a surface active agent, a diluent, a lubricant, a dispersing agent, etc. and a film-forming agent such as cellulose acetate phthalate may be incorporated in the preparation. Dose: 0.5W5,000mg/kg daily for adult for oral administration, and ≤100mg/kg for injection.
COPYRIGHT: (C)1981,JPO&Japio
JP8724379A 1979-07-10 1979-07-10 Carcinostatic agent Granted JPS5612311A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8724379A JPS5612311A (en) 1979-07-10 1979-07-10 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8724379A JPS5612311A (en) 1979-07-10 1979-07-10 Carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS5612311A true JPS5612311A (en) 1981-02-06
JPS638924B2 JPS638924B2 (en) 1988-02-25

Family

ID=13909361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8724379A Granted JPS5612311A (en) 1979-07-10 1979-07-10 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS5612311A (en)

Also Published As

Publication number Publication date
JPS638924B2 (en) 1988-02-25

Similar Documents

Publication Publication Date Title
CA1094455A (en) Tumor antidote
JPS5671074A (en) 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
JPS5692846A (en) Tetrapeptide derivative and its preparation
JPS5551020A (en) Remedy for rheumatism
JPS57109721A (en) Carcinostatic agent
JPS5612312A (en) Carcinostatic agent
JPS5612311A (en) Carcinostatic agent
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
JPS5612313A (en) Carcinostatic agent
JPS5758626A (en) Carcinostatic agent
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57128625A (en) Carcinostatic
JPS5533453A (en) Preventive and remedy for infectious disease of fish
JPS54125663A (en) Carcinostatic agent and novel compound having carcinostatic activity
JPS54125627A (en) Carcinostatic and novel compound having carcinostatic property
JPS5742620A (en) Novel antiulcer agent
JPS5731616A (en) Relaxing agent for muscle comprising benzofurancarboxylic acid amide
JPS57106621A (en) Preventing agent and remedy for fish disease
JPS57181012A (en) Drug composed of polyprenyl compound
JPS57114521A (en) Antidiabetic agent containing aminobenzoic acid derivative
JPS643121A (en) Remedy for endometriosis
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS5569510A (en) Carcinostatic agent
JPS57144216A (en) Antiulcer
JPS57126418A (en) Antiallergic agent